Research on TRPV1 channel-targeting drugs is complex and demanding, and a better understanding of TRPV1 function and post-antagonism in the RA paradigm should accelerate the development of TRPV1-targeted modulators. The gene discussed is TRPV1; the disease is rheumatoid arthritis.